Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Profound Medical (TSE:PRN)
TSX:PRN
Holding TSE:PRN?
Track your performance easily
PRN Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$9.55 - C$16.00
Previous CloseC$10.94
Volume7.42K
Average Volume (3M)7.87K
Market Cap
C$278.11M
Enterprise ValueC$239.99M
Total Cash (Recent Filing)$34.08M
Total Debt (Recent Filing)$6.65M
Price to Earnings (P/E)―
Beta0.11
Next Earnings
Nov 07, 2024EPS Estimate
-C$0.42Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.65
Shares Outstanding24,481,835
10 Day Avg. Volume6,319
30 Day Avg. Volume7,867
Standard Deviation0.25
R-Squared0.02
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)7.00
Price to Sales (P/S)25.15
Price to Cash Flow (P/CF)-7.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue30.46
Enterprise Value/Gross Profit54.77
Enterprise Value/Ebitda-9.24
Forecast
1Y Price Target
C$19.78Price Target Upside76.61% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Profound Medical News
PremiumCompany Announcements
Profound Medical Sees Strong Growth with TULSA-PRO®
PremiumCompany Announcements
Profound Medical’s TULSA Gains CMS Reimbursement Boost
PremiumCompany Announcements
Profound Medical’s Q3 Results and Innovations
PremiumCompany Announcements
Profound Medical Names New Chief Commercial Officer
PremiumCompany Announcements
Profound Medical Hosts Insightful Prostate Treatment EventOptions Prices
Currently, No data available
---
Ownership Overview
20.60% Insiders
1.81% Mutual Funds
8.27% Other Institutional Investors
69.26% Public Companies and
Individual Investors
PRN FAQ
What was Profound Medical’s price range in the past 12 months?
Profound Medical lowest stock price was C$9.55 and its highest was C$16.00 in the past 12 months.
What is Profound Medical’s market cap?
Currently, no data Available
When is Profound Medical’s upcoming earnings report date?
Profound Medical’s upcoming earnings report date is Nov 07, 2024 which is 3 days ago.
How were Profound Medical’s earnings last quarter?
Profound Medical released its earnings results on Aug 08, 2024. The company reported -C$0.389 earnings per share for the quarter, beating the consensus estimate of -C$0.392 by C$0.003.
Is Profound Medical overvalued?
According to Wall Street analysts Profound Medical’s price is currently Undervalued.
Does Profound Medical pay dividends?
Profound Medical does not currently pay dividends.
What is Profound Medical’s EPS estimate?
Profound Medical’s EPS estimate is -C$0.42.
How many shares outstanding does Profound Medical have?
Profound Medical has 24,481,834 shares outstanding.
What happened to Profound Medical’s price movement after its last earnings report?
Profound Medical reported an EPS of -C$0.389 in its last earnings report, beating expectations of -C$0.392. Following the earnings report the stock price went up 1.241%.
Which hedge fund is a major shareholder of Profound Medical?
Currently, no hedge funds are holding shares in TSE:PRN
---
Profound Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
C$19.78 (76.61% Upside)
C$19.78 (76.61% Upside)
Blogger Sentiment
Bullish
TSE:PRN Sentiment 100%
Sector Average 72%
Sector Average 72%
Insider Transactions
Bought Shares
Worth C$125.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-14.50%
12-Months-Change
Fundamentals
Return on Equity
-66.59%
Trailing 12-Months
Asset Growth
-8.92%
Trailing 12-Months
Company Description
Profound Medical
Profound Medical Corp is a medical technology company. It provides incision-free therapies that combine real-time Magnetic Resonance (MR) imaging, thermal ultrasound and closed-loop temperature feedback control for the radiation-free ablation of diseased tissue. The company develops a treatment to ablate the prostate gland in prostate cancer patients.
---
PRN Stock 12 Month Forecast
Average Price Target
C$19.78
▲(76.61% Upside)
Technical Analysis
Best Analysts Covering PRN
1 Year
1 Year Success Rate
5/12 ratings generated profit
1 Year Average Return
+2.33%
assigned a buy rating 5 days ago
Copying Ben Haynor's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of +2.33% per trade.
---